Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Pfizer
Roswell Park Cancer Institute
Pfizer
Baylor Research Institute
Institut du Cancer de Montpellier - Val d'Aurelle
Gruppo Oncologico del Nord-Ovest
National Cancer Institute (NCI)
Pfizer
Alliance for Clinical Trials in Oncology
UNICANCER
City of Hope Medical Center
NuCana plc
Institut Bergonié
IFOM ETS - The AIRC Institute of Molecular Oncology
Memorial Sloan Kettering Cancer Center
Pfizer
Baylor College of Medicine
UNC Lineberger Comprehensive Cancer Center
NRG Oncology
Charite University, Berlin, Germany
Memorial Sloan Kettering Cancer Center
Sun Yat-sen University